Table 2.
List of pre-clinical direct MYC inhibitors
| Mechanism | Type | Compound | References |
|---|---|---|---|
| Inhibitor of MYC/Max dimerization | Small Molecule | IIA6B17 | [672] |
| 10058-F4 | [673] | ||
| 10074-G5 | [674] | ||
| JY-3-094 | [675] | ||
| 3jc48–3 | [676] | ||
| MYCro1, MYCro2, MYCro3 | [677] | ||
| MYCMI-6 | [676] | ||
| KJ-Pyr-9 | [678] | ||
| EN4 | [679] | ||
| MYCi361 | [680] | ||
| MYCi975 | [681] | ||
| KI-MS2-008 | [682] | ||
| (Poly)peptide | OmoMYC | [683] | |
| FPPa-OmoMYC | [684] | ||
| Max bHLHZ (OmoMYC) | [685] | ||
| Mxd1 | [686] | ||
| Monoclonal antibody | [687] | ||
| H1 peptide | [688] | ||
| Inhibitor of E-box binding | Small Molecule | JKY-2-169 | [689] |
| (Poly)peptide | OmoMYC | [683] | |
| Max bHLHZ | [685] | ||
| Mxd1 | [686] | ||
| ME47 | [690] |